France | NATO DIANA Energy & Power 2026
Ultrasensitive and ultrafast immunoassays for toxin detection
NATO DIANA 2026 Cohort
Biocellis is developing breakthrough immunoassay technology based on a new generation of bioluminescence immunoassays. This patented technology provides ultra-sensitive and ultra-fast diagnostic results. It is designed to detect analytes with picogram-level sensitivity.
Biocellis's key differentiators are results in under 60 seconds, picogram-level sensitivity, and minimal sample preparation. This closes the critical gap between rapid tests that sacrifice sensitivity and sensitive tests that take too long. The technology is also designed to be ultra-scalable.
This technology is crucial because it eliminates the diagnostic bottleneck in critical situations, where timely and precise information is paramount. It enables faster intervention and better outcomes in emergencies, pandemics, or large-scale screening scenarios. The ability to detect toxins rapidly at picogram levels is vital for human resilience and safety.
Faster, more accurate diagnostics lead to quicker treatment decisions, potentially reducing healthcare costs associated with delayed diagnoses and improving patient outcomes. The ultra-scalable nature suggests cost-effectiveness at volume, offering a strong return on investment through enhanced operational efficiency and public health benefits. Early detection can prevent more severe, costly health issues.
Based on 'patented research developed over a decade' and the statement 'Now,' the technology is likely at a high Technology Readiness Level, possibly TRL 6-8. This suggests a functional prototype or system demonstration in a relevant environment, moving towards commercial readiness. It implies significant validation beyond basic research.
Biocellis offers a patented, next-generation bioluminescence immunoassay delivering ultra-fast (under 60 seconds) and ultra-sensitive (picogram-level) diagnostic results with minimal sample preparation. This technology addresses the critical need for rapid, precise diagnostics in emergencies, pandemics, and large-scale screening, closing the gap between speed and accuracy. It is particularly valuable for rapid toxin detection, enhancing human resilience and public safety.